Editas
CRISPR treatment for rare genetic eye disorder gains FDA study approval
Days after a Chinese researcher incensed the world of science with claims of editing the genomes of twin girls, an American ...
What next for Editas? First gene-editing company to go public
Is the Cambridge-based company Editas truly ready for the big time or is it trying to capitalize on technological hype? ...
